Market Snapshot

BSE Sensex: 78151.45 1.25%
BSE 500: 36505.4 0.48%
BSE 200: 11352.01 0.69%
BSE 100: 25871.39 0.93%
BSE BANKEX: 66194.59 1.58%
BSE IT: 28226.33 1.38%
Nifty 50: 24334.3 1.09%
Nifty 500: 23336.3 0.45%
Nifty 200: 14014.15 0.61%
Nifty 100: 25327.65 0.87%
Nifty Midcap 100: 62428.05 -0.41%
Nifty Small 100: 19296.3 -0.21%
Nifty IT: 29226.6 1.75%
Nifty PSU Bank: 8381.75 0.41%

News:

HDFC Bank Q1 PAT rises 5% YoY ...
ICICI Bank Q1 PAT rises 16% Yo...
Tata Technologies Q1 PAT grows...
India Cements reports turnarou...
Kotak Mahindra Bank Q1 PAT cli...

Lincoln Pharmaceuticals Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

Invest

17 Jul 2026 | 04:14 PM

597.00

-4.75 (-0.79%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Outperforms Index

5.41%

Return (1Y)

Beaten Nifty 50 by 8.51%
More Volatile

2.68%

Standard Deviation (1Y)

Higher than Nifty 50 by 1.83%
Not so consistent

6/12

Months

underperformed Nifty 50
AxisDirect View

No View

52 Week High-Low

770

440

News & Announcements

Board of Lincoln Pharmaceuticals recommends final dividend
50 days ago

Board of Lincoln Pharmaceuticals recommends final dividend

29 - May - 2026 12:00 | 50 days ago

Lincoln Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 28 May 2026, inter alia, have recommended the final dividend of Rs 1.8 per equity Share (i.e. 18%) , subject to the approval of the shareholders.

Lincoln Pharmaceuticals consolidated net profit rises 0.43% in the March 2026 quarter

50 days ago

Lincoln Pharmaceuticals to hold board meeting
60 days ago

Lincoln Pharmaceuticals to hold board meeting

19 - May - 2026 12:00 | 60 days ago

Lincoln Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28 May 2026.
Lincoln Pharmaceuticals consolidated net profit rises 37.70% in the December 2025 quarter
156 days ago

Lincoln Pharmaceuticals consolidated net profit rises 37.70% in the December 2025 quarter

12 - Feb - 2026 12:00 | 156 days ago

Net profit of Lincoln Pharmaceuticals rose 37.70% to Rs 28.60 crore in the quarter ended December 2025 as against Rs 20.77 crore during the previous quarter ended December 2024. Sales rose 13.49% to Rs 166.32 crore in the quarter ended December 2025 as against Rs 146.55 crore during the previous quarter ended December 2024.

Particulars Quarter Ended
Dec. 2025 Dec. 2024 % Var.

Sales 166.32 146.55 13

OPM % 14.18 16.14 -

PBDT 38.44 31.91 20

PBT 34.72 28.68 21

NP 28.60 20.77 38

Powered by Capital Market - Live News

Price vs Volume

1D
5D
1M
3M
1Y
3Y
5Y
MAX

Stock Trivia

FII shareholding in Lincoln Pharmaceuticals Ltd has decreased by -11.48% since past 3 Months
MF shareholding in Lincoln Pharmaceuticals Ltd has decreased by -4.76% since past 3 Months
FII shareholding in Lincoln Pharmaceuticals Ltd has decreased by -10.51% since past 1 Year
MF shareholding in Lincoln Pharmaceuticals Ltd has increased by 11.11% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

×

Online trading for clients based in USA and Canada is restricted. You can continue placing orders through mapped dealers offline

OK

vV5.0.0.6-60